EPISODE #173: What's Wrong With The Cannabis Industry? with Dr. Ethan Russo, Founder of Credo Science
Listen now
Description
What’s wrong with the cannabis industry? Joining us again on the latest episode of The Cannabis Conversation is Dr Ethan Russo, Founder of Credo Science -  a novel medical science company. We discuss the prejudice and ignorance against Cannabis, as well as safety monitoring, legalisation and some of the challenges the industry is facing, including a lack of proper funded research in the area. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Ethan Russo Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com  He is also Medical Director of Andira Pharmaceuticals Andira – Bringing Healing to Life and Senior Medical Advisor to Canurta Home | Canurta Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®. He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles. Resources Join Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/ View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_Russo CReDO Science Website: https://credo-science.com/
More Episodes
On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM). We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the...
Published 11/16/23
On the latest episode of The Cannabis Conversation, we speak with William Muecke of Artemis Growth Partners & Daniel Grözinger of Park Lane Capital. We look at the European Cannabis Industry from an investment perspective, including the benefits of the legal cannabis market in Germany and...
Published 10/03/23